Cargando…

Epidermal growth factor receptors (EGFR) in human ovarian cancer.

Epidermal growth factor receptor can be used as a biological marker in tumours. We examined 199 samples from 150 patients with ovarian cancer first by using a single point screen, then by full Scatchard analysis, over a concentration range between 0.086-16.6 nM. Taking as positive those samples whic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Owens, O. J., Stewart, C., Brown, I., Leake, R. E.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977444/ https://www.ncbi.nlm.nih.gov/pubmed/1931614

Ejemplares similares

Growth factors in ovarian cancer.
por: Owens, O. J., et al.
Publicado: (1991)

Epidermal Growth Factor Receptor (EGFR) Crosstalks in Liver Cancer
por: Berasain, Carmen, et al.
Publicado: (2011)

Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma
por: Wernicke, A Gabriella, et al.
Publicado: (2010)

AXL/epidermal growth factor receptor (EGFR) complexes in breast cancer - culprits for resistance to EGFR inhibitors?
por: Heideman, Marinus R, et al.
Publicado: (2013)

Targeting Epidermal Growth Factor Receptor (EGFR) in Pediatric Colorectal Cancer
por: De Pasquale, Maria Debora, et al.
Publicado: (2020)

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT)
por: Siddiqui, Mohammad R., et al.
Publicado: (2019)

Nuclear localization of epidermal growth factor receptor (EGFR) in ameloblastomas
por: Pereira, Núbia Braga, et al.
Publicado: (2015)

Human epidermal growth factor receptor targeted inhibitors for the treatment of ovarian cancer
por: Bonello, Maria, et al.
Publicado: (2018)

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas
por: Magkou, Christina, et al.
Publicado: (2008)

Hypermethylated Epidermal growth factor receptor (EGFR) promoter is associated with gastric cancer
por: Weng, Xiaoling, et al.
Publicado: (2015)

Immune Responses to Epidermal Growth Factor Receptor (EGFR) and Their Application for Cancer Treatment
por: Sasada, Tetsuro, et al.
Publicado: (2016)

Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR)
por: Kaufman, Nichole E. M., et al.
Publicado: (2021)

Epidermal growth factor receptor (EGFR) mutations in lung cancer: preclinical and clinical data
por: Jorge, S.E.D.C., et al.
Publicado: (2014)

Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small-Cell Lung Cancer (NSCLC)
por: O’Leary, Connor, et al.
Publicado: (2020)

Epidermal growth factor receptor (EGFR) gene promoter methylation and cetuximab treatment in colorectal cancer patients
por: Scartozzi, M, et al.
Publicado: (2011)

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance
por: Ranjbar, Reza, et al.
Publicado: (2015)

Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinoma
por: Abd El-Rehim, D M, et al.
Publicado: (2004)

Anti-Epidermal Growth Factor Receptor (EGFR) Antibodies Overcome Resistance of Ovarian Cancer Cells to Targeted Therapy and Natural Cytotoxicity
por: Gottschalk, Nina, et al.
Publicado: (2012)

Association of epidermal growth factor receptor (EGFR) gene polymorphisms with endometriosis
por: Wang, Yu-Mei, et al.
Publicado: (2019)

Effect of BRCA1 on epidermal growth factor receptor in ovarian cancer
por: Li, Da, et al.
Publicado: (2013)

Association of Cortactin, Fascin-1 and Epidermal Growth Factor Receptor (EGFR) Expression in Ovarian Carcinomas: Correlation with Clinicopathological Parameters
por: Lin, Chih-kung, et al.
Publicado: (2008)

Targeting the Epidermal Growth Factor Receptor in EGFR-Mutated Lung Cancer: Current and Emerging Therapies
por: Khaddour, Karam, et al.
Publicado: (2021)

The prognostic value of epidermal growth factor receptor mRNA expression in primary ovarian cancer.
por: Bartlett, J. M., et al.
Publicado: (1996)

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications
por: Zimmermann, Michel, et al.
Publicado: (2006)

Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance
por: Maramotti, Sally, et al.
Publicado: (2016)

The Association between Epidermal Growth Factor Receptor (EGFR) Gene Polymorphisms and Lung Cancer Risk
por: Bashir, Nabil A., et al.
Publicado: (2018)

Impact of concurrent genomic alterations in epidermal growth factor receptor (EGFR)-mutated lung cancer
por: Gini, Beatrice, et al.
Publicado: (2020)

Therapeutic Implications of Epidermal Growth Factor Receptor (EGFR) in the Treatment of Metastatic Gastric/GEJ Cancer
por: Adashek, Jacob J., et al.
Publicado: (2020)

Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer
por: Harrison, Peter T., et al.
Publicado: (2020)

Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer
por: Hong, Chang‐Soo, et al.
Publicado: (2020)

The status of epidermal growth factor receptor in borderline ovarian tumours
por: Showeil, Rania, et al.
Publicado: (2016)

Piperonylic acid stimulates keratinocyte growth and survival by activating epidermal growth factor receptor (EGFR)
por: Lee, Dohyun, et al.
Publicado: (2018)

Discovery of Promising Inhibitors of Epidermal Growth Factor Receptor (EGFR), Human Epidermal Growth Factor Receptor 2 (HER2), Estrogen Receptor (ER), and Phosphatidylinositol-3-kinase a (PI3Ka) for Personalized Breast Cancer Treatment
por: Akinnusi, Precious A, et al.
Publicado: (2022)

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer
por: Peraldo-Neia, Caterina, et al.
Publicado: (2011)

Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
por: Makinoshima, Hideki, et al.
Publicado: (2014)

Transactivation of epidermal growth factor receptor through platelet-activating factor/receptor in ovarian cancer cells
por: Yu, Yi, et al.
Publicado: (2014)

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
por: Rayego-Mateos, Sandra, et al.
Publicado: (2018)

Toward structure-based drug design against the epidermal growth factor receptor (EGFR)
por: Haddad, Yazan, et al.
Publicado: (2020)

Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors
por: Barnes, Precious, et al.
Publicado: (2020)

Screening and discovery of nitro-benzoxadiazole compounds activating epidermal growth factor receptor (EGFR) in cancer cells
por: Sakanyan, Vehary, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a360o89u261s0u0jh1eknr6iok